Dhampur Bio Organics Ltd (IN:DBOL)
:DBOL
Want to see IN:DBOL full AI Analyst Report?
Top Page
Dhampur Bio Organics Ltd
(DBOL)
Select Model
Select Model
Rating:48Neutral
Price Target:
₹105.00
▲(33.54% Upside)
Action:Reiterated
Date:05/31/26
The score is held back primarily by compressed profitability and inconsistent cash generation, alongside moderate leverage and much weaker ROE. Technicals add further pressure with bearish momentum (below 20/50DMA and negative MACD), despite near-oversold readings. Valuation is not especially supportive given the elevated P/E and only modest dividend yield.
Positive Factors
Integrated sugar-ethanol model
Integration of sugar milling, distillery and by-product use creates durable operational flexibility and margin support. The firm can shift output mix (sugar vs ethanol) and use bagasse/molasses internally for energy or external sale, cushioning revenue and cost cycles over months.
Negative Factors
Compressed profitability
Margins have materially compressed versus recent years, eroding return on capital and limiting internal reinvestment. Persistently thin net margins reduce resilience to input cost shocks and make earnings sensitive to modest volume or price changes over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Integrated sugar-ethanol model
Integration of sugar milling, distillery and by-product use creates durable operational flexibility and margin support. The firm can shift output mix (sugar vs ethanol) and use bagasse/molasses internally for energy or external sale, cushioning revenue and cost cycles over months.
Read all positive factors
Dhampur Bio Organics Ltd (DBOL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹7.59B
Dividend Yield1.63%
Average Volume (3M)4.15K
Price to Earnings (P/E)30.2
Beta (1Y)0.96
Revenue Growth13.31%
EPS Growth73.17%
CountryIN
Employees1,637
SectorConsumer Defensive
Sector Strength42
IndustryAgricultural Farm Products
Share Statistics
EPS (TTM)0.00
Shares Outstanding66,387,590
10 Day Avg. Volume4,096
30 Day Avg. Volume4,146
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)0.75
Price to Sales (P/S)0.36
P/FCF Ratio6.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dhampur Bio Organics Ltd Business Overview & Revenue Model
Company Description
Dhampur Bio Organics Ltd., founded in 2020 and headquartered in New Delhi, India, functions as a holistic sugarcane processing enterprise. The company's operations in India involve the manufacturing and distribution of various products, such as re...
How the Company Makes Money
DBOL primarily makes money by selling (1) sugar and related sugar products and (2) ethanol produced through its distillery operations, with additional contributions from co-/by-products generated during sugarcane processing.
1) Sugar sales (core ...
Dhampur Bio Organics Ltd Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
58
Neutral
Cash Flow
46
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.12B | 21.09B | 18.62B | 18.39B | 24.08B | 15.54B |
| Gross Profit | 4.69B | 3.39B | 4.76B | 3.65B | 5.50B | 2.20B |
| EBITDA | 1.17B | 1.31B | 1.38B | 1.59B | 2.13B | 1.90B |
| Net Income | -500.00K | 251.80M | 146.90M | 464.90M | 1.11B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 16.45B | 23.22B | 23.98B | 23.13B | 20.77B | 20.01B |
| Cash, Cash Equivalents and Short-Term Investments | 564.30M | 361.60M | 389.80M | 293.90M | 1.04B | 229.80M |
| Total Debt | 5.62B | 10.60B | 11.62B | 10.57B | 8.10B | 8.35B |
| Total Liabilities | 6.83B | 12.95B | 13.86B | 13.01B | 10.89B | 11.23B |
| Stockholders Equity | 9.62B | 10.27B | 10.12B | 10.11B | 9.89B | 8.77B |
Cash Flow | ||||||
| Free Cash Flow | 6.69B | 1.15B | -161.70M | -2.72B | 1.45B | -4.08B |
| Operating Cash Flow | 6.89B | 1.59B | 1.30B | -1.01B | 3.55B | -2.46B |
| Investing Cash Flow | -178.20M | -422.00M | -1.46B | -1.66B | -1.96B | -1.38B |
| Financing Cash Flow | -6.52B | -1.17B | 187.90M | 1.70B | -781.20M | 3.94B |
Dhampur Bio Organics Ltd Technical Analysis
Positive
78.63
Price Trends
113.96
Positive
105.33
Positive
92.61
Positive
Market Momentum
-0.23
Negative
57.65
Neutral
60.05
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:DBOL, the sentiment is Positive. The current price of 78.63 is below the 20-day moving average (MA) of 108.86, below the 50-day MA of 113.96, and below the 200-day MA of 92.61, indicating a bullish trend. The MACD of -0.23 indicates Negative momentum. The RSI at 57.65 is Neutral, neither overbought nor oversold. The STOCH value of 60.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:DBOL.
Dhampur Bio Organics Ltd Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Neutral | ₹45.19B | 15.43 | ― | 1.01% | 15.75% | 4.87% | |
63 Neutral | ₹247.72B | 23.67 | ― | ― | 17.28% | -14.64% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | ₹108.73B | 22.99 | ― | 1.92% | 9.06% | 9.97% | |
52 Neutral | ₹2.98B | 32.73 | ― | 0.46% | -25.39% | -37.39% | |
48 Neutral | ₹7.59B | 30.20 | ― | 1.63% | 13.31% | 73.17% | |
42 Neutral | ₹780.67M | 90.66 | ― | ― | -11.26% | -75.85% |
* Consumer Defensive Sector Average
IN:DBOL
Dhampur Bio Organics Ltd
114.40
35.04
44.15%
IN:AWL
Adani Wilmar Limited
190.60
-73.80
-27.91%
IN:GODREJAGRO
Godrej Agrovet Limited
565.25
-198.30
-25.97%
IN:KSCL
Kaveri Seed Co. Ltd.
878.50
-442.24
-33.48%
IN:SAKUMA
Sakuma Exports Limited
1.90
-1.27
-40.06%
IN:UMAEXPORTS
Uma Exports Ltd.
23.09
-36.46
-61.23%
Dhampur Bio Organics Ltd Corporate Events
Dhampur Bio Organics Publishes Q4 and FY26 Investor Presentation
May 30, 2026
Dhampur Bio Organics Ltd has released its investor presentation for the fourth quarter and full year ended March 31, 2026, detailing the company’s financial and operational performance. The presentation, which has been shared with stock exch...
Dhampur Bio Organics Chairman Vijay Kumar Goel Passes Away, Triggering Leadership Transition
May 10, 2026
Dhampur Bio Organics Ltd. has announced the death of its Chairman and Executive Director, Vijay Kumar Goel, who passed away on May 10, 2026, prompting formal disclosure to the BSE and NSE in line with Indian listing regulations. The board and empl...
Dhampur Bio Organics to Sell Meerganj Sugar Unit, Launch JV in Functional Foods
Apr 20, 2026
Dhampur Bio Organics Ltd’s board has approved the transfer of its Meerganj sugar factory in Bareilly, Uttar Pradesh, as a going concern on a slump-sale basis to Forever Global Enterprises, signaling a strategic reshaping of its manufacturing...
Dhampur Bio Organics to Sell Meerganj Sugar Unit, Launch JV in Functional Foods
Apr 20, 2026
Dhampur Bio Organics Ltd. has approved the transfer of its Meerganj sugar factory in Bareilly, Uttar Pradesh, as a going concern on a slump sale basis to Forever Global Enterprises Ltd., marking a significant portfolio reshaping of its core sugar ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.